134 related articles for article (PubMed ID: 31122889)
1. Study of direct costs of type 1 diabetes mellitus in Andalusian patients aged 2-16 years.
Álvarez Casaño M; Alonso Montejo MDM; Leiva Gea I; Jiménez Hinojosa JM; Santos Mata MÁ; Macías F; Romero Pérez MDM; de Toro M; Martínez G; Munguira P; Vivas G; López Siguero JP
Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):480-486. PubMed ID: 31122889
[TBL] [Abstract][Full Text] [Related]
2. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
Giménez M; Elías I; Álvarez M; Quirós C; Conget I
Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
[TBL] [Abstract][Full Text] [Related]
3. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
[TBL] [Abstract][Full Text] [Related]
4. Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012.
Bruno G; Pagano E; Rossi E; Cataudella S; De Rosa M; Marchesini G; Miccoli R; Vaccaro O; Bonora E
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1104-1111. PubMed ID: 27817991
[TBL] [Abstract][Full Text] [Related]
5. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
7. [Direct health care costs in patients with type 2 diabetes mellitus six months after starting insulin treatment in Spain: the INSTIGATE study].
Costi M; Smith H; Reviriego J; Castell C; Goday A; Dilla T
Endocrinol Nutr; 2011; 58(6):274-82. PubMed ID: 21641287
[TBL] [Abstract][Full Text] [Related]
8. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.
Reviriego J; Gomis R; Marañés JP; Ricart W; Hudson P; Sacristán JA
Int J Clin Pract; 2008 Jul; 62(7):1026-32. PubMed ID: 18489577
[TBL] [Abstract][Full Text] [Related]
9. Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.
Guillermin AL; Samyshkin Y; Wright D; Nguyen T; Villeneuve J
J Med Econ; 2011; 14(2):207-16. PubMed ID: 21361858
[TBL] [Abstract][Full Text] [Related]
10. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
Schiel R; Müller UA; Stein G
Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.
Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T
Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of MiniMed 640G with SmartGuard® System for prevention of hypoglycemia in pediatric patients with type 1 diabetes mellitus.
Villafuerte Quispe B; Martín Frías M; Roldán Martín MB; Yelmo Valverde R; Álvarez Gómez MÁ; Barrio Castellanos R
Endocrinol Diabetes Nutr; 2017 Apr; 64(4):198-203. PubMed ID: 28417874
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK.
Thalange N; Gundgaard J; Parekh W; Tutkunkardas D
BMJ Open Diabetes Res Care; 2019; 7(1):e000664. PubMed ID: 31543973
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
[No Abstract] [Full Text] [Related]
15. Social economic costs of type 1 diabetes mellitus in pediatric patients in Spain: CHRYSTAL observational study.
López-Bastida J; López-Siguero JP; Oliva-Moreno J; Perez-Nieves M; Villoro R; Dilla T; Merino M; Jiang D; Aranda-Reneo I; Reviriego J; Vázquez LA
Diabetes Res Clin Pract; 2017 May; 127():59-69. PubMed ID: 28319803
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
17. Linear association between household income and metabolic control in children with insulin-dependent diabetes mellitus despite free access to health care.
Deladoëy J; Henderson M; Geoffroy L
J Clin Endocrinol Metab; 2013 May; 98(5):E882-5. PubMed ID: 23539732
[TBL] [Abstract][Full Text] [Related]
18. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
Schnell O; Erbach M
J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
[TBL] [Abstract][Full Text] [Related]
19. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
20. [Study of the quality of life and adherence to treatment in patients from 2 to 16 years-old with type 1 diabetes mellitus in Andalusia, Spain].
Álvarez Casaño M; Alonso Montejo MDM; Leiva Gea I; Jiménez Hinojosa JM; Santos Mata MÁ; Macías F; Romero Pérez MDM; de Toro M; Martínez G; Munguira P; Vivas G; López Siguero JP
An Pediatr (Engl Ed); 2021 Feb; 94(2):75-81. PubMed ID: 32540137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
